William Devaney

-Leading a DOJ / SFO FCPA and UK Bribery Act investigation for a FTSE 100 company, involving over a dozen jurisdictions, resulting in a declination of prosecution from both agencies. -Winning a motion to dismiss on behalf of a large retailer in a False Claims Act action brought by the New York Attorney General, alleging the failure to remit tens of millions of dollars in sales tax. -Representing a European global engineering company in a False Claims Act investigation led by the US Attorney's Office for the Southern District of New York, resulting in a declination. -Successfully representing a publicly traded consumer goods company in a parallel securities fraud investigation by the US Attorney's Office for the Central District of California and the SEC. -Co-lead a team that successfully challenged a portion of the Florida election law seeking to restrict voter registration. -Representing a US based global pharmaceutical company in an internal investigation relating to alleged falsification of pharmacovigilance testing in Latin America. -Advising a US based global pharmaceutical company regarding its response and investigation into allegations of improper information sharing between a senior employee and an employee of a competitor. -Representing a global engineering company in a sanctions investigation conducted by the US Attorney's Office for the Eastern District of New York. -Representing a large South American agricultural company in a money laundering investigation conducted by the US Attorney's Office for the Southern District of Florida, in which the company and its owner were deemed targets when we entered, but we ultimately won a full declination. -Conducting an internal investigation for a global European energy conglomerate into allegations of bribery and embezzlement in six Latin American jurisdictions. -Conducting an internal investigation for a Swiss private bank into allegations of money laundering. -Conducting an internal investigation for a global Japanese electronics company involving allegations of bribery in multiple African countries. -Conducting an internal investigation regarding potential sanctions and ITAR violations for a global automotive manufacturer's military trucks division. -Representing a life sciences executive in a criminal investigation conducted by the US Attorney's Office for the Eastern District of Pennsylvania relating to false statements on customs documents and in FDA filings. -Representing a pharmaceutical executive in the DOJ generic pharmaceutical antitrust investigation and related civil class action litigation. -Successfully representing a senior executive in the Alcon / Novartis FCPA and SEC matters. -Successfully representing an executive of a global pharmaceutical company in an SEC investigation related to the company's distributors and other third parties in the Middle East. -Representing an individual defendant in the FIFA prosecution brought by the US Attorney's Office in the Eastern District of New York, defeating the government's extradition bid, and before InterPol. -Representing an executive in the DOJ Volkswagen Diesel investigation, resulting in a declination of prosecution. -Successfully representing a world famous celebrity in an internal investigation and follow-on civil lawsuit alleging sexual assault. -Successfully representing a Chinese company and its US subsidiary in a civil RICO action in federal court in New Jersey. -Successfully represented a commercial real estate company and its owner against allegations of civil RICO and fraud. -Conducting risk assessments, designing and advising on anti-corruption compliance programs, conducting third party due diligence and providing day to day compliance advice for companies in the life sciences, industrial, consumer goods and technology sectors. -Conducting pre-transactional M&A and JV compliance due diligence for clients in a variety of industries. -Providing compliance advice to a global hospitality company as it expands into the Middle East. -Designing a US compliance program for a large European medical device company upon its expansion by acquisition into the US.